Ọkwa ọgwụ USP EP BP 148408-66-6 Docetaxel trihydrate maka ọgwụgwọ ọrịa kansa Tumor
Ngwaahịaaha | Docetaxel Trihydrate |
Ụdị okwu | (αR, βS) -β-[[(1,1-dimethylethoxy) carbonyl] amino]-a-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS) -12b -(acetyloxy) -12- (benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13 ,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4] benz [1,2-b] oxet-9-yl ester, hydrate (1:3) |
CAS Mba. | 148408-66-6 |
Ọdịdị | Uzuzu crystalline na-acha ọcha ruo na-acha ọcha |
Usoro ihe omimi | C43H53NO14.3 (H2O) |
Ibu molekụla | 861.94 |
Ngwa | Ọkwa ọgwụ ma ọ bụ ebumnuche nyocha |
Nkwakọ ngwaahịa | Dị ka arịrịọ gị si dị |
Nchekwa | Chekwaa n'ime akpa siri ike, nke na-enweghị ọkụ n'ebe dị mma |
NGWA | Ọkọlọtọ | Nsonaazụ |
Ndị agwa | A: Na-acha ọcha na-acha ọcha crystalline ntụ ntụ | Dabara |
B: Solubility: Insoluble na mmiri, soluble na ethanol na acetone | Dabara | |
KpọtụrụRotation | ﹣38.5°~﹣41.5° | ﹣40° |
njirimara | 1.IR: Otu ka ịlele sample | Dabara |
2.UV: λmax232nm | Dabara | |
| Dabara | |
| Dabara | |
Ihe adịghị ọcha | Mkpokọta adịghị ọcha: NMT 1.0% | 0.29% |
Ihe adịghị ọcha A: NMT 0.5% | 0.0551% | |
Ihe adịghị ọcha B: NMT 0.3% | 0.0470% | |
Ihe adịghị ọcha C: NMT 0.3% | 0.0535% | |
Otu adịghị ọcha ọ bụla: NMT 0.1% | 0.0702% | |
Mmiri | 5.0% - 7.0% | 6.15% |
Ihe fọdụrụ na mgbanye | NMT 0.1% w/w | 0.03% |
Igwe dị arọ | NMT 20pm | Dabara |
Nyocha | 97.5% ~ 102.0% | 99.7% |
Mmechi | Ọ na-ezute EP7.5. |
Ozi ụlọ ọrụ
√ Ahụmahụ zuru oke nke oyi akwa na ụlọ ọrụ mmepụta ihe na ndị na-eso ụzọ teknụzụ nwere nkà; √ Quality bụ mgbe anyị n'elu echiche, siri ike QC usoro; √ 11 afọ nwere ahụmahụ mbupụ ahịa otu; √ ụlọ nyocha R&D nọọrọ onwe ya; √ Ụlọ ọrụ GMP abụọ bịanyere aka na ogologo oge; √ Akụ bara ụba nke ọtụtụ ụlọ ọrụ na-abaghị uru maka ọrụ ahaziri iche; √ Ndị otu na-arụ ọrụ nke ọma na ụzọ na-agbanwe agbanwe.Dee ozi gị ebe a ziga anyị ya